Adherence to Precautionary Guidelines for Compounding Antineoplastic Drugs: A Survey of Nurses and Pharmacy Practitioners

REFERENCES

• Valanis, B.G., W.M. Vollmer, K.T. Labuhn, and A.G. Glass: Acute symptoms associated with antineoplastic drug handling among nurses. Cancer Nurs. 16:288–295 (1993).
   PubMed Web of Science ®Google Scholar
• Valanis, B.G., W.M. Vollmer, K.T. Labuhn, and A.G. Glass: Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel. Am. J. Hosp. Pharm. 50:455–462 (1993).
   PubMedGoogle Scholar
• Skov, T., B. Maarup, J. Olsen, M. Rorth, J. Winthereik, and E. Lynge: Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. Br. J. Ind. Med. 49:855–861 (1992).
   PubMedGoogle Scholar
• Valanis, B., W. Vollmer, K. Labuhn, and A.G. Glass: Occupational exposure to antineoplastic agents and self-reported infertility among nurses and pharmacists. J. Occ. Env. Med. 39(6):574–580 (1997).
   PubMed Web of Science ®Google Scholar
• Connor, T.H., and M.A. McDiarmid: Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer J. Clin. 56:354–365 (2006).
   PubMed Web of Science ®Google Scholar
• Rekhadevi, P.V., N. Sailaja, M. Chandrasekhar, M. Mahboob, M.F. Rahman, and P. Grover: Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs. Mutagenesis 22(6):395–401 (2007).
   PubMed Web of Science ®Google Scholar
• Villarini, M., L. Dominici, R. Piccinini, R., et al.: Assessment of primary, oxidative and excision repaired DNA damage in hospital personnel handling antineoplastic drugs. Mutagenesis 26(3) 359–369 (2011).
   PubMed Web of Science ®Google Scholar
• Lawson, C.C., C.M. Rocheleau, E.A. Whelan, et al.: Occupational exposures among nurses and risk of spontaneous abortions. Am. J. Obstet. Gynecol. 206: 327.e1–8 (2012).
   Google Scholar
• Suspiro, A., and J. Prista: Biomarkers of occupational exposure do anticancer agents: a minireview. Toxicol. Lett. 207:42–52 (2011).
   PubMed Web of Science ®Google Scholar
• McDiarmid, M.A., M.S. Oliver, T.S. Roth, B. Rogers, and C. Escalante: Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. J. Occup. Environ. Med. 52:1028–1034 (2010).
   PubMed Web of Science ®Google Scholar
• American Society of Hospital Pharmacists (ASHP): Technical assistance bulletin on handling cytotoxic drugs in hospitals. Am. J. Hosp. Pharm. 42:131–137 (1985).
   Google Scholar
• Occupational Safety and Health Administration: Guidelines for cytotoxic (antineoplastic) drugs. Instruction publication 8-1.1, 1986. . Available at: https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=DIRECTIVES&p_id=1702 (accessed March 25, 2014)
   Google Scholar
• Oncology Nursing Society: Cancer chemotherapy guidelines; Modules I-V. Oncology Nursing Society, Pittsburgh, PA (1988).
   Google Scholar
• National Institute for Occupational Safety and Health: NIOSH Alert: Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. Cincinnati, Ohio: National Institute for Occupational Safety and Health, 2004. Available at: http://www.cdc.gov/niosh/docs/2004-165 (accessed March 25, 2014)
   Google Scholar
• The United States Pharmacopeial Convention. Chapter 797 Pharmaceutical compounding-sterile preparations. Revision Bulletin, 2008. . Available at: www.doh.wa.gov/Portals/1/Documents/2300/USP797GC.pdf (accessed January 25, 2015)
   Google Scholar
• Manuele, F.A.: Risk assessment and hierarchy of control. Prof. Safety 50:33–39 (2005).
   Google Scholar
• Stajicj, G.V., C.W. Barnett, S.V. Turner, and C.A. Henderson: Protective measures used by oncology office nurses handling parenteral antineoplastic agents. Oncol. Nurs. Forum 13:47–49 (1986).
   PubMedGoogle Scholar
• Valanis, B. and L. Stortridge: Self protective practices of nurses handling antineoplastic drugs. Oncol Nurs. Forum 14:23–27 (1987).
   PubMedGoogle Scholar
• Mahon, S.M., D.S. Casperson, S. Yackzan, S. Goodner, et al.: Safe handling practices of cytotoxic drugs: the results of a chapter survey. Oncol. Nurs. Forum 21:1157–1165 (1994).
   PubMedGoogle Scholar
• Martin, S., and E. Larson: Chemotherapy-handling practices of outpatient and office-based oncology nurses. Oncol. Nurs. Forum 30:575–581 (2003).
   PubMedGoogle Scholar
• Fuller, T.P., E.I. Bain, K. Sperrazza, and L.F. Mazzuckelli: A survey of the status of hazardous drug awareness and control in a sample massachusetts nursing population. J. Occup. Environ. Hyg. 4: 11, D113–D119 (2007).
   PubMed Web of Science ®Google Scholar
• Valanis, B., V. McNeil, and K. Driscoll: Staff members’ compliance with their facility's antineoplastic drug handling policy. Oncol Nurs. Forum 19:571–576 (1991).
   Google Scholar
• Valanis, B., W.M. Vollmer, K. Labuhn, A. Glass, and C. Corelle: Antineoplastic drug handling protection after OSHA guidelines. Comparison by profession, handling activity, and work site. J. Occup. Med. 34:149–155 (1992).
   Web of Science ®Google Scholar
• Polovich, M., and S. Martin: Nurses’ use of hazardous drug-handling precautions and awareness of national safety guidelines. Oncol. Nurs. Forum 38:718–726 (2011).
   PubMed Web of Science ®Google Scholar
• Polovich, M., and P.C. Clark: Factors influencing oncology nurses’ use of hazardous drug safe-handling precautions. Oncol. Nurs. Forum 39:E299–E309 (2012).
   PubMedGoogle Scholar
• Boiano, J.M., A.L. Steege, and M.H. Sweeney: Adherence to safe handling guidelines by healthcare workers who administer antineoplastic drugs. J. Occup. Environ. Hyg. 11:728–740 (2014).
   PubMed Web of Science ®Google Scholar
• Steege, A.L., J.M. Boiano, and M.H. Sweeney: NIOSH health and safety practices survey of healthcare workers: training and awareness of employer safety procedures. Am. J. Ind. Med. 57(6):640–652 (2014).
   PubMed Web of Science ®Google Scholar
• American Society of Health-System Pharmacists: ASHP guidelines on handling hazardous drugs. Am. J. Health-Sys. Pharm. 63:1172–1193 (2006).
   Google Scholar
• Occupational Safety and Health Administration: Controlling Occupational Exposure to Hazardous Drugs. In: OSHA Technical Manual, TED 1-0.15A, section VI, chapter 2., 1999. Available at: http://www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html. (accessed March 25, 2014)
   Google Scholar
• National Institute for Occupational Safety and Health: Workplace Solutions: Personal Protective Equipment for Health Care Workers who Work with Hazardous Drugs. Cincinnati, Ohio: National Institute for Occupational Safety and Health. Available at: http://www.cdc.gov/niosh/docs/wp-solutions/2009-106/ (accessed March 25, 2014).
   Google Scholar
• Polovich, M., J.M. Whitford, and M. Olsen, eds: Chemotherapy and Biotherapy Guidelines and Recommendations for Practice. 3rd ed. Pittsburgh, PA: Oncology Nursing Society (2009).
   Google Scholar
• National Institute for Occupational Safety and Health: NIOSH List of Antineoplastic and Other Hazardous Drugs in Health Care Settings, 2010. Cincinnati, Ohio: National Institute for Occupational Safety and Health. Available at: http://www.cdc.gov/niosh/docs/2010-167 (accessed March 25, 2014)
   Google Scholar
• Centers for Disease Control and Prevention (CDC): Distinguishing Public Health Research and Public Health Nonresearch, 2010. Available at: http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf (accessed March 25, 2014)
   Google Scholar
• Pedersen, C.A., Schneider, P.J., and D.J. Scheckelhoff: ASHP national survey of pharmacy practice in hospital settings: dispensing and administration-2011. Am. J. Health-Syst. Pharm. 69:768–785 (2012).
   PubMed Web of Science ®Google Scholar
• Connor, T.H., R.W. Anderson, P.J. Sessink, and S.M. Spivey: Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.v. admixture area. Am. J. Health-Syst. Pharm. 59:68–72 (2002).
   PubMed Web of Science ®Google Scholar
• Clark, B.A. and P.J.M. Sessink: Use of a closed-system drug transfer device eliminates surface contamination with antineoplastic agents. J. Oncol. Pharm. Practice 19:99–104 (2013).
   PubMedGoogle Scholar
• Sessink, P.J., J. Trahan, and J.W. Coyne: Reduction in surface contamination with cyclophosphamide in 30 US hospital pharmacies following implementation of a closed-system drug transfer device. Hosp. Pharm. 48:204–212 (2013).
   PubMedGoogle Scholar
• Occupational Safety and Health Administration: Hazard Communication (1910.1200). Available at: https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=standards&p_id=10099. (accessed February 2, 2015)
   Google Scholar
• Hon, C.Y., K. Teschke, W. Chu, et al.: Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals. J. Occup. Environ. Hyg. 10:374–383 (2013).
   PubMed Web of Science ®Google Scholar
• Hon, C.Y., K. Teschke, P.A. Demers, and S. Venners: Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system. J. Occup. Hyg. 1–10, doi: 10.1093/annhyg/meu019 (2014).
   Web of Science ®Google Scholar
• National Institute for Occupational Safety and Health: Medical Surveillance for Healthcare Workers Exposed to Hazardous Drugs. Cincinnati, Ohio: National Institute for Occupational Safety and Health, 2012 Available at: http://www.cdc.gov/niosh/docs/wp-solutions/2013-103/pdfs/2013-103.pdf (accessed March 25, 2014)
   Google Scholar
• Friese, C.R., L. Himes-Ferris, M.N. Frasier, M.C. McCullagh, and J.J. Griggs: Structures and processes of care in ambulatory oncology settings and nurse-reported exposure to chemotherapy. BMJ Qual. Safety 21:753–759 (2011).
   Google Scholar